GP-Act III Acquisition (GPAT) Earnings Analysis
GP-Act III Acquisition (GPAT) has no confirmed upcoming earnings date. Trailing P/E 34.85.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does GPAT next report earnings?
No confirmed upcoming earnings date is currently scheduled for GPAT. This page updates as the calendar is published.
GPAT earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
GPAT valuation and analyst view
| Trailing P/E | 34.85 |
|---|---|
| Trailing EPS | 0.38741 USD |
| Price / book | 1.06 |
| Dividend yield | 0.00% |
| Market cap | 0.39B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is GP-Act III Acquisition (GPAT)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for GPAT. This page updates as the calendar is published.
What is GPAT's current P/E ratio and EPS?
GPAT trades at a trailing P/E of 34.85 on trailing EPS of 0.38740984347826085 USD.
What do analysts rate GPAT?
GPAT has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.